Background endothelial progenitor cells (epCs) derived from bone marrow migrate to areas of endothelial damage and repair them. epC function is impaired by oxidative stress. We examined the effects of an antioxidative β 1 -adrenoceptor blocker on the number and function of epCs in hypertensive rats.
β-Adrenoceptor blockers (β-blockers) are a group of drugs that are widely used in the treatment of cardiovascular diseases including arterial hypertension. The therapeutic effects of β-blockers are explained by their capacity to block β-adrenoceptors, thereby inhibiting the effects of the endogenous agonists, noradrenaline and adrenaline. 1 The beneficial cardiovascular effects of some β-blockers have been shown to be associated with their antioxidant properties. Propranolol has been reported to combat oxidative stress through its antioxidant activity, and to reduce tissue lipid peroxidation. 2 Recent studies have shown that carvedilol acts as a free radical scavenger to decrease lipid peroxidation in patients with heart failure. 3 It has also been reported that celiprolol decreases the production of superoxide anions in patients with essential hypertension 4 and improves endothelial function. 5 In contrast, treatment with atenolol has no effect on the excessive production of reactive oxygen species (ROS) in endothelial cells. 6 These studies indicate that only certain β-blockers act as effective antioxidants. The excessive production of ROS is the root mechanism underlying the pathogenesis of endothelial dysfunction and cardiovascular diseases. It follows, therefore, that the antioxidant action of β-blockers might contribute to their beneficial effects in the context of cardiovascular diseases.
Hypertension can result in cardiovascular complications such as stroke and ischemic heart disease, which are associated with arterial damage. Although cardiovascular risk factors such as hypertension, dyslipidemia, and diabetes mellitus primarily cause vascular injury, including endothelial damage, it is believed that abnormalities in the repair of endothelial damage enhance vascular injury. Endothelial progenitor cells (EPCs) derived from bone marrow represent up to 0.01% of cells in the peripheral blood. EPCs migrate to areas of endothelial damage and repair them, and this would suggest that EPC dysfunction determines the eventual level of vascular injury. 7 Hill et al. 8 reported that EPC dysfunction is closely correlated with vascular injury and endothelial function in the context of various cardiovascular risk factors such as hypertension, dyslipidemia, diabetes mellitus, and smoking. The mechanisms underlying EPC dysfunction in hypertension have not yet been determined. It has been reported that the life spans (cell cycles) of stem cells, including those of EPCs, are decreased by oxidative stress. 9 Therefore it is possible that oxidative stress induces endothelial damage by decreasing the life span and/or function of EPCs.
In order to investigate whether antioxidative β-blockers exert beneficial effects on EPCs, the in vivo effects of celiprolol on oxidative stress and the number and function of EPCs were studied in high-salt-loaded spontaneously hypertensive rats (SHRs).
Methods
Animals and experimental design. Experiments were performed on 12-week-old male Wistar-Kyoto (WKY)/Izm rats and SHRs/Izms (SHR, Hamamatsu, Shizuoka, Japan). All procedures described in this study were approved by the Animal Experimentation Committee of the Nihon University School of Medicine. The rats were housed (three per cage) under controlled conditions of temperature, humidity, and light, and had unrestricted access to water. WKY rats (n = 6) and SHRs (n = 18) received a high-salt diet (8% NaCl) for 2 weeks, and SHRs that had been fed a high-salt diet were randomly assigned to one of three groups: (i) untreated SHRs (n = 6); (ii) SHRs treated with atenolol (Sigma-Aldrich, St. Louis, MO) (n = 6); and (iii) SHRs treated with celiprolol (Nippon Shinyaku, Kyoto, Japan) (n = 6). The first group received only drinking water; the second group received atenolol (25 mg/kg/ day) dissolved in drinking water, for 2 weeks; and the third group received celiprolol (50 mg/kg/day) dissolved in drinking water, for 2 weeks.
Systolic blood pressure and heart rate were measured weekly in the mornings throughout the 2-week period using the tailcuff method and a blood pressure monitor (model BO-98A; Softron, Tokyo, Japan). The average of three successive readings was recorded. The rats were anesthetized with intraperitoneal sodium pentobarbital (50 mg/kg) after 2 weeks, and the kidneys, aorta, and heart were flushed with ice-cold phosphate-buffered saline and removed immediately. Kidney cortex, aorta, and heart were stored at −80 °C until use in RNA extraction.
Blood samples were collected through a needle inserted directly into the heart prior to, and at 1 and 2 weeks after the start of the treatments. Plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured by radioimmunoassay (SRL, Tokyo, Japan).
EPC colony formation assay. A modified EPC colony formation assay was performed as described previously. 10 In brief, the rats were anesthetized with intraperitoneal sodium pentobarbital (50 mg/kg), and 10 ml of heparinized peripheral blood was collected through the hepatic portal vein. Mononuclear cells (MNCs) were separated in Histopaque-1083 density-gradient medium (Sigma-Aldrich). The MNCs were suspended and mixed in 1 ml endothelial growth medium-2 (Clonetics, San Diego, CA) containing 10% fetal bovine serum, human basic fibroblast growth factor, vascular endothelial growth factor, recombinant insulin-like growth factor-1, human epidermal growth factor, and ascorbic acid (Clonetics). Twenty-four-well plates (BD Biosciences, San Jose, CA) were precoated with rat vitronectin (0.1 μg/cm 2 ) plus 0.5% gelatin overnight at 37 °C. The MNCs were inoculated onto six-well plates (5 × 10 6 cells/well) and cultured for 24 h. Nonadherent MNCs were reinoculated onto vitronectin-coated plates (2 × 10 6 cells/well) and cultured in a CO 2 incubator at 37 °C for 7 days. The average number of colonies was calculated manually under a microscope from a minimum of four wells by an observer who was unaware of the experimental design.
Flow cytometric analysis for EPCs. We determined the number of circulating EPCs in peripheral blood using cell-surface antigen as previously established. 11 Circulating MNCs with CD34 + were tentatively quantified as EPCs. Peripheral blood was drawn and the MNCs were isolated using a density-gradient centrifuge method. The MNCs were stained with a fluorescein isothiocyanate-conjugated anti-CD34 monoclonal antibody (BD Biosciences). Samples were subjected to a 2D side-scatterfluorescence dot plot analysis (FACScan; BD Biosciences). After appropriate gating, the number of CD34 + cells with low cytoplasmic granularity (low sideward scatter) was quantified and expressed as the number of cells per 10 4 total events.
EPC migration assay. In order to investigate EPC migration activity, a modified Boyden chamber assay was performed with a 96-well microchemotaxis chamber (Neuro Probe, Gaithersburg, MD) as described previously. 12 In brief, after inoculation onto six-well plates for 24 h, nonadherent MNCs were resuspended in endothelial basic medium-2 (Clonetics). Chemotaxis assays were performed in 96-microwell chemotaxis chambers (Neuro Probe) with 5-μm pore size, vitrogen (Cohesion Technologies (Palo Alto, CA))-coated polycarbonate filters (Neuro Probe). The same medium, containing 10% fetal bovine serum, 50 ng/ml stromal-derived factor 1 (R&D Systems, Minneapolis, MN), 50 ng/ml vascular endothelial growth factor-A (R&D Systems), and 0.1% bovine serum albumin (negative control) was applied to the lower compartment, and cells were adjusted to 5 × 10 4 cell/ml and applied to the upper compartment. After incubating in a CO 2 incubator at 37 °C for 24 h, the filter was removed, and cells that migrated to the filter were washed once with phosphate-buffered saline, fixed, stained with Diff-Quick (Sysmex International Reagents Co., Ltd., Tokyo, Japan), and counted under a microscope at ×40 magnification. The number of migrated cells in the treated samples minus the number of cells migrated in negative controls was counted. All assays were performed at least in triplicate.
Senescence-associated β-galactosidase assay. Senescenceassociated β-galactosidase assay was performed as previously described. 12 In brief, attached MNCs in endothelial basic articles Anti-Oxidative β-Blocker on EPC medium-2 were fixed for 3 min in 2% paraformaldehyde at room temperature, washed again, and incubated for 24 h at 37 °C (no CO 2 ) with fresh SA-β-Gal stain solution (1 mg/ml 5-bromo-4-chloro-3-indyl D-galactopylanoside, 5 mmol/l potassium ferrocyanide, 5 mmol/l potassium ferricyanide, 150 mmol/l NaCl, 2 mmol/l MgCl 2 , 0.01% sodium deoxycholate, and 0.02% Nonidet-40). The MNCs were counterstained with 4ʹ,6-diamino-phenylindole (0.2 g/ml in 10 mmol/l Tris-HCl, pH 7.0, 10 mmol/l EDTA, 100 mmol/l NaCl) for 10 min to count the total number of cells.
Thiobarbituric acid-reactive substance assay. Thiobarbituric acid-reactive substance (TBARS) in MNCs was measured using an Oxi-Tek TBARS assay kit (ZeptoMetrix, Buffalo, NY). In brief, MNCs (10 6 /100 μl) were mixed with 100 μl sodium dodecyl sulfonate solution. TBA/buffer reagent was prepared by mixing 0.5 g thiobarbituric acid with 50 ml acetic acid and 50 ml NaOH. TBA/buffer reagent (2.5 ml) was added to 200 μl sample/sodium dodecyl sulfonate mixture and incubated at 95 °C in capped tubes for 60 min. The samples were cooled to room temperature in an ice bath for 10 min and centrifuged at 3,000 r.p.m. for 15 min. The supernatants were removed, and fluorescence intensity was measured in semi-microcuvettes in a fluorometer (Bio-Rad Laboratories, Hercules, CA). The concentration of TBARS was expressed in pmol/10 6 cells by interpolation from a standard curve of malondialdehyde at concentrations of 0-200 pmol.
Real-time PCR. Total RNA was isolated from rat kidney, aorta, and heart using Isogen reagent (Nippon Gene, Toyama, Japan) in accordance with the manufacturer's instructions. Aliquots of total RNA were reverse transcribed into single-stranded complementary DNA by incubating with avian myeloblastoma virus reverse transcriptase (TaKaRa Bio, Shiga, Japan). Measurements of tissue complementary DNA levels were performed by realtime PCR using a PRISM 7500 Sequence Detection System (Applied Biosystems, Foster City, CA). All of the probes and primers were Assays-on-Demand Gene Expression Products (p22 phox , Rn00577357_ml; p47 phox , Rn00586945_ml; gp91 phox , Rn00576710_ml; and TaqMan Rodent GAPDH control reagents; Applied Biosystems). Each reaction mixture consisted of 12.5 μl TaqMan Universal PCR Master Mix (Applied Biosystems), 50 ng complementary DNA template, and 1.25 μl specific probe/primer mixed in a total volume of 25 μl. The amplification conditions were: 50 °C for 2 min and 95 °C for 10 min followed by 60 cycles of denaturation (95 °C for 15 s) and combined annealing/extension (60 °C for 1 min). The threshold cycle (C t ) was subsequently determined. Relative quantification of marker gene mRNA expression was carried out using the comparative C t method. 13 Relative quantification values of the target, normalized to values of an endogenous control (glyceraldehyde 3-phosphate dehydrogenase gene) and relative to a calibrator were expressed as 2-ΔΔC t (fold difference).
Statistical analysis.
Values are reported as mean values ± s.e.m. Statistical analysis was performed using Student's t-test for unpaired data and one-way analysis of variance. P < 0.05 was considered statistically significant. results changes in blood pressure and heart rate with β-blockers Systolic blood pressure was significantly (P < 0.05) higher in salt-loaded SHRs than in salt-loaded WKY rats. Treatment with either atenolol or celiprolol produced similar significant decreases (P < 0.05) in systolic blood pressure in salt-loaded SHRs (Figure 1a) . Treatment with atenolol, but not celiprolol, significantly (P < 0.05) decreased heart rate in salt-loaded SHRs (Figure 1b) .
Pac and Pra
Figure 1c,d shows levels of PAC and PRA from WKY rats and SHRs before and after salt loading and treatments with atenolol or celiprolol. Treatments with atenolol or celiprolol did not affect the levels of PAC and PRA.
effect of celiprolol on ePc colony formation and circulating ePc numbers
The culture of MNCs for 7 days resulted in the formation of EPC colonies (Figure 2a,b) . The number of EPC colonies was significantly less in the MNCs of SHRs than in those of WKY rats (P < 0.01). The number of EPC colonies in SHRs treated with celiprolol was significantly higher (P < 0.01) than in untreated SHRs. Treatment with atenolol did not increase the number of EPC colonies as compared to the control (Figure 2c) .
The number of circulating EPCs in peripheral blood was significantly (P < 0.01) lower in SHRs than that in WKY rats heart rate in salt-loaded Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (sHrs) left untreated (n = 6) or treated with atenolol (25 mg/kg/day; n = 6) or with celiprolol (50 mg/kg/day; n = 6) for 2 weeks. Levels of (c) plasma aldosterone concentration (pAC) and (d) plasma renin activity (prA) in salt-loaded WKY rats and sHrs left untreated or treated with atenolol or celiprolol. blood samples were collected through a needle inserted directly into the heart in rats prior to, and at 1 and 2 weeks after the start of the treatments. pAC (n = 5) and prA (n = 5) were measured by radioimmunoassay. the data are shown as mean values ± s.e.m. *P < 0.05 vs. untreated sHrs. articles Anti-Oxidative β-Blocker on EPC (Figure 2d,e) . The number of EPCs in SHRs treated with celiprolol was significantly higher than in untreated SHRs (P < 0.01). Treatment with atenolol did not affect the number of circulating EPCs in SHRs.
effect of celiprolol on ePc migration
The effects of atenolol or celiprolol on EPC migration in the presence of vascular endothelial growth factor-A, stromal-derived factor-1, or fetal bovine serum are shown in Figure 3 . The migration index was significantly (P < 0.05) lower in SHRs than in WKY rats. EPC migration in response to vascular endothelial growth factor, stromal-derived factor-1, or fetal bovine serum was significantly higher (P < 0.05) in SHRs treated with celiprolol than in untreated SHRs. Treatment with atenolol had no effect on EPC migratory activity. The proportion of senescence-associated β-galactosidasepositive cells was significantly (P < 0.01) higher in SHRs than in WKY rats (Figure 4a,b) . The number of β-galactosidase-positive cells in SHRs treated with celiprolol was significantly lower than in untreated SHRs (P < 0.01). Treatment with atenolol did not affect the number of β-galactosidase-positive cells. The TBARS score in MNCs was significantly (P < 0.01) greater in SHRs than that in WKY rats (Figure 4c) . Treatment with celiprolol significantly decreased (P < 0.01) the TBARS score in SHRs, while treatment with atenolol did not affect the increased TBARS score.
effect of celiprolol on the expression of nad(P)h oxidase components
The effects of atenolol or celiprolol on the mRNA expression of nicotinamine adenine dinucleotide phosphate (NAD(P)H) oxidase components in aorta, heart, and renal cortex are shown in Figure 5 . The prevalence of gp91 phox , p22 phox , and p47 phox mRNAs in SHRs were significantly (P < 0.01) greater than in WKY rats. Treatment with celiprolol significantly (P < 0.01) decreased gp91 phox and p22 phox mRNA levels in the aorta, heart, and renal cortex in SHRs and also significantly decreased p47 phox mRNA expression in the heart. Treatment with atenolol did not affect the mRNA expression of NAD(P)H oxidase subunits in SHRs.
discussion
Hypertension causes endothelial dysfunction and vascular remodeling, which may be associated with abnormalities in the repair of endothelial damage. Stem and progenitor cells are critical for organogenesis during fetal development. Recently, the existence of somatic stem cells has been reported in adult organs; these cells are thought to migrate to and repair damaged tissues and organs. EPCs have potential to differentiate into mature functional endothelial cells. In adults, circulating EPCs localize to sites of neovascularization and differentiate into endothelial cells. 14, 15 The repair of injured vessel walls and the generation of new blood vessels require stem cells or EPCs. 16 EPCs circulate in the peripheral blood and are directly exposed to systemic oxidative stresses in hypertension. It has been reported that the pro-oxidant conditions associated with hypertension may determine EPC function and fate. 17 In this study, we show that the oxidative stress levels in MNCs from SHRs was significantly greater than in those from WKY rats. The pathogenesis of hypertension is strongly associated with an increased production of tissue angiotensin II (Ang II). 18 Increased Ang II in hypertension directly induces increases in blood pressure and cardiovascular damage by increasing the production of growth factors and oxidative stress. Oxidative stress has been implicated in the pathogenesis of Ang II-related hypertension. 19 Ang II, acting through the Ang II type I receptor, stimulates NAD(P)H oxidase, induces oxidative stress, and alters endothelial cell function. 20 In this study, we show that mRNA expression of NAD(P)H oxidase components such as gp91 phox , p22 phox , and p47 phox was increased in heart, aorta, and renal cortex in salt-loaded SHRs. ROS are produced in the cardiovascular system by various cell types, including endothelial cells, vascular smooth muscle cells, adventitial fibroblasts, and macrophages, primarily through the production of superoxide radical (O 2 − ). In the cardiovascular system, O 2 − is produced in large part by the enzyme NAD(P)H oxidase. 21 By this mechanism, oxidative stress is increased in salt-loaded SHRs.
The life span of stem and progenitor cells, including EPCs, has been reported to be shortened by oxidative stress, 22 and the functions of EPCs, such as migration, may be critically influenced by the redox equilibrium state. 23 Oxidative stress is involved in telomere shortening, which influences cellular life span. 24 Studies of neural progenitor cells have shown that factors that promote self-renewal cause these cells to enter a decreased redox state, whereas exposure to factors that promote differentiation leads to excess oxidation. 25 It follows, therefore, that oxidation may be involved in the balance between self-renewal and differentiation. The redox balance changes as cells mature, suggesting that antioxidants may play major roles in the preservation of characteristics of articles Anti-Oxidative β-Blocker on EPC stem cells and progenitor cells. The functions of EPCs, such as migration, affect the patient's recovery after cell transplantation. 26 Imanishi et al. 27 reported that exposure of EPCs to oxidized low-density lipoprotein significantly accelerate EPC senescence, diminish telomerase activity, and impair EPC proliferative capacity and network formation. We have demonstrated that the formation and function of EPCs are impaired by oxidative stress, and that ARBs improve the proliferation and function of EPCs in hypertensive rats. 7, 28 These findings suggest that the biochemical basis of EPC dysfunction involves excessive oxidative stress, and that EPCs that are subjected to the unfavorable environment of oxidative stress may undergo senescence or apoptosis.
In this study we also show that celiprolol, but not atenolol, decreases the elevated TBARS score in MNCs from SHRs, thereby suggesting that celiprolol decreases oxidative stress in hypertension. In addition, celiprolol, but not atenolol, significantly inhibits the increased mRNA expression of NAD(P)H oxidase components. This finding would suggest that celiprolol may reduce the production of ROS in salt-loaded SHRs by suppressing NAD(P)H oxidase expression. The ability of celiprolol to inhibit oxidative stress has been evaluated in various in vivo studies. Kobayashi et al. 29 reported that celiprolol inhibits NAD(P)H oxidase expression and decreases production of H 2 O 2 in deoxycorticosterone acetate/salt-hypertensive rats. In addition, celiprolol has been reported to decrease production of superoxide anions in patients with essential hypertension, 4 whereas atenolol had no effect on excessive ROS production in endothelial cells. 6 Therefore our findings, together with those of others, strongly suggest that celiprolol is an effective antioxidant for use in hypertension.
Both celiprolol and atenolol were shown to reduce blood pressure to similar levels; however, only celiprolol, but not atenolol, markedly enhanced EPC numbers and function. This finding would suggest that the beneficial effect of celiprolol on EPCs is independent of its effect on blood pressure. The number and function of EPCs from SHRs were lower than those in EPCs from WKY rats. Celiprolol did not affect the levels of PAC and PRA, thereby indicating that the improvement in EPC colony formation by celiprolol is not associated with the suppression of PAC and PRA. In addition, the proportion of senescence-associated cells was significantly higher in SHRs than in WKY rats. These data suggest that the decreases in EPC number were associated with apoptosis and senescence by oxidative stress in SHRs. Celiprolol effectively increased EPC number and colony formation, stimulated EPC migration, and decreased EPC senescence with reduction of oxidative stress.
In conclusion, the results of this study show that EPC number and function are decreased in hypertension, and that this is associated with oxidative stress. Celiprolol may increase EPC number and function by suppressing EPC senescence and apoptosis through reduction of oxidative stress in hypertension, thereby adding to its beneficial cardiovascular effects. The use of celiprolol as a conventional pharmacological treatment to improve the number and function of EPCs and reduce cardiovascular damage in hypertension shows promise.
